Role & Responsibilities
• Engage with hemato-oncologists and lymphoma KOLs to build scientific advocacy for CART Therapy (Qartemi) in r/r B-NHL
• Support patient identification by educating physicians on clinical eligibility and screening pathways
• Serve as the Single Point of Contact (SPOC) for site onboarding, discharge, and follow-up
• Collect real-world data of patients on CART therapy for PMS/RWE
• Prepare case studies for scientific discussions and assist in publication writing
• Facilitate onboarding of new sites by guiding medical criteria, infrastructure, and readiness
• Conduct scientific discussions on CAR T mechanism, efficacy, and management of CRS/ICANS
• Execute regional CMEs, tumor board participation, and non-promotional education initiatives
• Collect and communicate field insights to medical and commercial teams for strategic alignment
• Ensure scientific accuracy and compliance in all engagements, serving as the medical face of Qartemi
Qualifications
• MD, MBBS, PharmD (or equivalent degree)
Experience
• Fresher or 0 years of experience in Medical Affairs, preferably in Oncology/Hemato-oncology
Skills
• Scientific knowledge in oncology/hemato-oncology
• Strong communication and scientific writing skills
• Results-oriented, ethical, and customer-oriented
• Analytical skills to assess clinical data and field insights
About The Company
• Immuneel Therapeutics is a pioneering start-up specializing in cell therapy and personalized immunotherapy for patients in India. The company is committed to driving patient outcomes and is focused on delivering innovative solutions in the field of cell and gene therapy.
Unlock refined AI insights.